AZD3043

DRUG4 trials

Sponsors

AstraZeneca

Conditions

HealthyPharmacokineticsSafetySedationTolerability

Phase 1

Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD3043

CompletedNCT00918515

AstraZenecaHealthy

Start: 2009-05-31End: 2009-08-31Updated: 2009-08-28

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043

CompletedNCT00984880

AstraZenecaHealthy

Start: 2009-09-30End: 2009-12-31Target: 72Updated: 2009-12-18

AZD Single Ascending Dose Study In Healthy Japanese Subjects

CompletedNCT01028040

AstraZenecaHealthy

Start: 2009-12-31End: 2010-08-31Target: 72Updated: 2010-12-10

Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043

WithdrawnNCT01086813

AstraZenecaPharmacokinetics, Safety, Sedation +1

Start: 2010-03-31End: 2010-04-30Updated: 2012-12-20

Related Papers

A Bolus and Bolus Followed by Infusion Study of AZD3043, an Investigational Intravenous Drug for Sedation and Anesthesia: Safety and Pharmacodynamics in Healthy Male and Female Volunteers.

2015-10-0111 citations